Tielemans, C. L., Vlasak, J., Kosa, D., Billiouw, J., Verpooten, G. A., Mezei, I., . . . Surquin, M. (2011). Immunogenicity and safety of an investigational AS02v-adjuvanted hepatitis B vaccine in patients with renal insufficiency who failed to respond or to maintain antibody levels after prior vaccination: Results of two open, randomized, comparative trials. Vaccine, 29(6), . https://doi.org/10.1016/j.vaccine.2010.12.009
Chicago-Zitierstil (17. Ausg.)Tielemans, Christian L., et al. "Immunogenicity and Safety of an Investigational AS02v-adjuvanted Hepatitis B Vaccine in Patients with Renal Insufficiency Who Failed to Respond or to Maintain Antibody Levels After Prior Vaccination: Results of Two Open, Randomized, Comparative Trials." Vaccine 29, no. 6 (2011). https://doi.org/10.1016/j.vaccine.2010.12.009.
MLA-Zitierstil (9. Ausg.)Tielemans, Christian L., et al. "Immunogenicity and Safety of an Investigational AS02v-adjuvanted Hepatitis B Vaccine in Patients with Renal Insufficiency Who Failed to Respond or to Maintain Antibody Levels After Prior Vaccination: Results of Two Open, Randomized, Comparative Trials." Vaccine, vol. 29, no. 6, 2011, https://doi.org/10.1016/j.vaccine.2010.12.009.